KENYON LAWRENCE A 4
4 · Outlook Therapeutics, Inc. · Filed Apr 20, 2021
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Purchase
Common Stock
2021-04-20$1.83/sh+10,000$18,300→ 18,926 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within a $1.00 range. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.